Journal
Oncotarget
Publication Date
1-1-2022
Volume
13
First Page
273
Last Page
280
Document Type
Open Access Publication
DOI
10.18632/oncotarget.28188
Rights and Permissions
Shah AN, Sunderraj A, Finkelman B, See SH, Davis AA, Gerratana L, Wehbe F, Katam N, Mahalingam D, Gradishar WJ, Behdad A, Blanco L, Cristofanilli M. Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers. Oncotarget. 2022 Feb 2;13:273-280. doi: 10.18632/oncotarget.28188. © 2022 Shah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Shah, Ami N; Sunderraj, Ashwin; Finkelman, Brian; See, Sharlene H; Davis, Andrew A; Gerratana, Lorenzo; Wehbe, Firas; Katam, Neelima; Mahalingam, Deva; Gradishar, William J; Behdad, Amir; Blanco, Luis; and Cristofanilli, Massimo, "Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers." Oncotarget. 13, 273 - 280. (2022).
https://digitalcommons.wustl.edu/oa_4/517
